Categories: Research

Shoichet research one of top breakthroughs for 20097

Thu Jan 7, 2010
Wired Science has cited a computational model developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, and applied and tested by scientists at the University of North Carolina at Chapel Hill School of Medicine, as one of the Top Scientific Breakthroughs...

Wells uses small molecules to trigger cell death8

Wed Dec 16, 2009
Research directed by senior author James Wells, PhD, chair of the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, has opened the door to a new way of studying and better understanding the processes of cell death (apoptosis), blood clotting, and other biochemical pathways.

Method to predict polypharmacology developed in Shoichet Lab9

Tue Dec 15, 2009
A computational method developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, has the potential to predict new target diseases for existing drugs as well as unexpected side effects of approved drugs.

UCSF innovation among top 10 for 200910

Mon Dec 7, 2009
The Scientist has cited a UCSF innovation among its top 10 list of tools to hit the life sciences in 2009. In the spotlight is a paper that reveals how to import plant "light switches" into mammalian cells to control complex regulatory processes. The paper appeared in the October 15, 2009 issue of...

Craik to lead Takeda-sponsored research on antibodies11

Mon Nov 2, 2009
Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S. Craik, PhD, faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy.

Kroetz discusses pharmacogenomics on KQED Quest radio12

Fri Oct 16, 2009
UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009. Fellow members of the interview panel were UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, and UCSF breast cancer...

Study identifies lack of information about HER2 testing practices13

Fri Oct 16, 2009
Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...

UCSF researchers join consortium to target cancer in new ways14

Thu Oct 15, 2009
Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

Voigt Lab programs bacteria to perform increasingly complicated tasks15

Wed Oct 14, 2009
UCSF School of Pharmacy researchers and colleagues have successfully created a mathematical model that genetically programs bacteria and causes the bacteria to "trace" images projected onto them in a petri dish. The bacteria sense and display the area of the projection where light meets dark by...

Bero serves on IOM committee that reports on conflict of interest16

Wed Sep 30, 2009
UCSF School of Pharmacy researcher Lisa Bero, PhD, served with UCSF School of Medicine colleagues Bernard Lo, MD, and Deborah Grady, MD, MPH, on an Institute of Medicine (IOM) committee that in spring 2009 published its findings on conflict of interest in medical research, education, and practice.

Pages